Dive into the complex world of healthcare reimbursement in Germany with this podcast episode, where the market access expert, Dr. Stefan Walzer, unlocks the intricacies of evaluating and integrating new diagnostic methods into the outpatient reimbursement catalogue. Join us as we explore the critical requirements for assessment, the pivotal role of the evaluation committee, a sub-committee of the German Federal Committee (G-BA), and the nuanced process of price setting in this unique healthcare landscape.
In an enlightening conversation with Prof. Jürgen Wasem, the Head of the arbitration board for the evaluation committee, we peel back the layers of this rigorous evaluation process, offering listeners an exclusive look at the inner workings of healthcare reimbursement decisions and the strategic considerations behind them.
Listen to the podcast: here